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ABSTRACT
Objectives: To determine semen quality and
reproductive hormone levels in young Faroese men.
Design: Descriptive cross-sectional study of Faroese
men compared with Danish men.
Setting: Faroese one-centre study.
Participants: 481 men born from 1981 to 1987 and
investigated from 2007 to 2010.
Outcome measures: Sperm concentration, semen
volume, total sperm count, sperm motility, sperm
morphology and reproductive hormone levels.
Results: Sperm concentrations for the Faroese men
were lower than for the Danish men (crude median
40 vs 48 mill/ml, p<0.0005). Semen volume was
higher, and thus the total sperm counts did not differ
(159 vs 151 mill, p=0.2). Motility and morphology did
not differ between the Faroese and Danes. The inhibin
B/follicle-stimulating hormone ratios for the Faroese
men were lower than for the Danes (64 vs 76,
p=0.001). Similarly, lower total testosterone/luteinising
hormone (LH) ratio (4.6 vs 6.0, p<0.0005) and lower
calculated free-testosterone/LH ratio (94 vs 134,
p<0.0005) were detected for the Faroese men.
Conclusions: Semen quality among the Faroese men
is at the same low level as reported for Danish men,
and the reproductive hormone levels furthermore
indicated a lower Leydig cell capacity for testosterone
production. The influence of environmental exposure
and genetic factors on semen quality has to be studied
further.
INTRODUCTION
In 1992, Carlsen et al1 published a combined
analysis of results from 61 papers published
between 1939 and 1991 and showed a signiﬁ-
cant decline in sperm counts over a 50-year
period. A detailed reanalysis of the results
found that the conclusion was supported by
the underlying studies.2 3 Following the 1992
publication, many analysed retrospectively
their historical data for temporal trends,
some ﬁnding a decline and others not.
Realising that the trend analyses indicated
that semen quality could have reached a low
level where it might affect fecundity, several
prospectively designed cross-sectional semen
quality studies were initiated to determine
the current quality in men from general
populations. These studies not only revealed
geographical differences4 5 but also con-
ﬁrmed the general presence of low semen
ARTICLE SUMMARY
Article focus
▪ Semen quality studies have not been conducted
in the Faroe Islands before.
▪ Owing to the Faroese population differing from
other populations regarding, for example, high
exposure to persistent organic pollutants (POPs)
and genetic diseases, the semen quality of the
Faroese men from the general population would
be expected to be low.
Key messages
▪ The semen quality among Faroese men is at the
same low level as reported in Denmark.
▪ The low inhibin B/follicle-stimulating hormone
ratio for the Faroese men corroborates the
finding of low sperm counts and provides inde-
pendent evidence of poorer testicular function in
the Faroese men than in the Danes.
▪ Similarly, the Leydig cell capacity for testoster-
one production was also lower for the Faroese
men than for the Danes.
Strengths and limitations of this study
▪ Prospectively designed, cross-sectional study of
testicular function among young men from the
general population unselected with regard to
fertility.
▪ Standardised inclusion and investigation
procedures.
▪ Clinical examination for one subgroup of Faroese
men, but not for the other.
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quality in men from all investigated countries when the
results were interpreted according to available publica-
tions focused on associations between semen quality and
fertility chances.6–9
The causes of decreased semen quality are not clear,
but it is feasible that many cases may have been caused by
exposure to environmental factors in utero, during ado-
lescence or in adulthood;10 however, most likely acting
on a background of different genetic susceptibility.
The Faroese population differs from other populations
in many respects. The Faroese population has high
exposure to persistent organic pollutants (POPs)
derived from traditional marine food, which includes
blubber from the pilot whale. At the same time, there
are several genetic diseases reported with very high fre-
quency in the Faroese Islands.11 Thus, our hypothesis
was that the semen quality of Faroese men from the
general population would be quite low.
MATERIALS AND METHODS
To test our hypothesis, we investigated the semen quality
of young Faroese men from the general population
in 2007–2010. For comparison, we used a recently
published similar group of Danish men examined in
2006–201012 and the current WHO reference levels.13
Study population: men from the general Faroese
population
The entire study population consisted of 484 men, ori-
ginating from two separate studies. The ﬁrst study group
included 241 randomly selected young men examined
between February 2007 and February 2009 (F1). The
second group comprised 243 men examined between
November 2009 and November 2010 (F2). A detailed
description of the study population based on question-
naire information and results from the physical examin-
ation (see below) is summarised in table 1. Within
3 months prior to participation, 132 men (27.4%) had
used medication, mainly antibiotics, painkillers or
asthma/allergy medicine.
Faroese men, examined 2007–2009 (subgroup F1)
Invitation letters to participate in the study were sent to
1100 men, consecutively listed in the Faroese population
register as born between January 1981 and December
1984, followed by a phone call to arrange the examin-
ation details. A total of 34 men had emigrated, and
43 letters were returned as undeliverable. Thus, 1023
were invited. Of these, 490 could not be reached and
292 declined to participate. Hence, the ﬁnal F1 group
comprised 241 men (24% of all invited).
Faroese men, examined 2009–2010 (subgroup F2)
This group consisted of a cohort generated from
consecutive births at the three Faroese hospitals during
1986–1987 (N=509 men) as described elsewhere.14–16
Detailed information on their physical health and
potential environmental factors was collected at the time
of birth and during the course of follow-up at ages 7, 14
and 22 years. The 421 men who had participated in the
22-year follow-up were invited to participate in the
semen quality study. This was the sole selection criterion.
All men received a letter of invitation and subsequently
a phone call to arrange the examination details. Among
the 421 invited men, 243 agreed to participate, but 3 did
not succeed in delivering a semen sample. Hence, the
ﬁnal F2 group comprised 240 men (57% of all invited).
Questionnaire
On the day of attendance, the men returned a question-
naire they had received in advance. The questionnaire
was based on that used for young Danish men12 17 and
included information on previous or current diseases,
including any known history of fertility potential and
some lifestyle factors like smoking and drinking habits.
Semen samples
Semen samples were produced by masturbation in a
room close to the semen laboratory. The period of
abstinence was recorded. The abstinence time was
obtained differently in the two Faroese subgroups. In F1,
the men were asked directly by the physician about the
abstinence time while the F2 men themselves wrote
down their abstinence time after they had some time to
consider. The semen sample was analysed according to
the WHO 1999 guidelines.18 Semen volume was esti-
mated by weighing the collection tube with the semen
sample and subtracting the weight of the empty pre-
weighed tube, assuming that 1 ml semen=1 g. For sperm
motility assessment, 10 µl of well-mixed semen was
placed on a clean glass slide kept at 37°C and covered
with a 22×22 mm coverslip. The preparation was placed
on the heated stage of a microscope at 37°C and imme-
diately examined at ×400 magniﬁcation. The sperm were
classiﬁed as progressive motile (WHO class AB motility),
locally motile (WHO class C motility) or immotile
(WHO class D motility).
For the assessment of the sperm concentration, the
samples were diluted in distilled water. The sperm con-
centration was subsequently assessed using a
Bürker-Türk haemocytometer (Paul Marienfeld GmbH
& Co. KG, Lauda-Königshofen, Germany). However, a
second delivery of Bürker-Türk chambers was 0.05 mm
in depth rather than the standard 0.1 mm we had
ordered. Because of that, 59 samples from F2 were ana-
lysed without knowing whether 0.05 or 0.1 mm deep
counting chambers were used. As the semen samples
had been stored in our bio-bank, the 59 samples were
measured again with the 0.1 mm deep chamber to indi-
cate if the original concentration assessment was correct
(assuming that the 0.1 mm counting chamber was used
originally) or should be doubled (assuming that the
0.05 mm counting chamber was used originally). Based
on these reanalyses, the obtained original sperm con-
centrations were doubled for 23 samples (see online
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Table 1 Physical appearance and self-reported information of Faroese and Danish men
Faroese men (F1) Faroese men (F2)
p Value*
Faroese men (F1+F2) Danish men (D)
p Value*2007–2009 (N=241) 2009–2010 (N=240) 2007–2010 (N=481) 2006–2010 (N=1274)
Physical appearance
Age (years) 25.3 (24.2–26.7) 23.0 (22.0–24.0) <0.0005 24.0 (22.0–26.2) 19.0 (18.4–21.8) <0.0005
Height (cm) 180.0 (169.9–189.9) 180.0 (170.0–193.0) 0.1 180.0 (170.0–191.0) 181.6 (171.1–193.0) <0.0005
Weight (kg) 80.3 (64.2–106.2) 78.00 (62.9–105.1) 0.2 80.0 (63.1–105.9) 74.1 (60.1–96.0) <0.0005
BMI (kg/m2) 25.0 (20.6–32.3) 24.3 (20.4–32.1) 0.03 24.6 (20.5–32.1) 22.4 (18.7–28.6) <0.0005
Testes size (ml)† 21.5 (15.3–25.0) NA NA 23 (14–29)
Lifestyle
Alcohol per week (units) 5(0–25) 6 (0–26) 0.08 5 (0–25) 12 (0–42) <0.0005
Current smokers 44.0 41.3 0.5 42.6 45.4 0.4
Mother smoked in pregnancy 22.4‡ 37.5 0.05 33.6 29.1 0.4
Taken medication§ 23.7 31.3 0.07 27.4 15.1 <0.0005
Been treated for¶
Cryptorchidism** 3.3 7.5 0.04 5.4 5.0 0.8
Been diagnosed as having††
Cryptorchidism reported 8.7 12.1 0.2 10.4 6.9 0.02
Hypospadias 0.4 0.8 0.6 0.6 0.3 0.4
Sexually transmitted disease‡‡ 9.1 10.8 0.5 10.0 6.2 0.007
Phimosis 10.0 11.7 0.5 10.8 4.6 <0.0005
Varicocele 0.8 0.8 1.0 0.8 0.4 0.6
Have§§
Ever caused a pregnancy† 25.7 NA NA 6.8 –
Fatherhood 21.2 6.3 <0.0005 13.7 NA –
Experienced fertility problems¶¶ 4.6 1.7 0.07 3.1 0.2 <0.0005
Results shown as medians (5–95th percentile) or percentages.
*Mann-Whitney test.
†Mean of two testes. Testes size was not measured in Faroese men born in 1986–1987, and the question ‘Have you ever caused a pregnancy’ was not asked in this group.
‡Information only available for 189 mothers.
§Taken any medication 3 months prior to participation in the study.
¶‘Have you ever been treated for…’
**Hormonal, surgical or combination.
††‘Has a doctor ever diagnosed you as having.....’
‡‡Chlamydia, gonorrhoea, warts or herpes.
§§Have you ever…’
¶¶Ever had regular intercourse without use of contraception for at least 6 months (Faroese men) or 1 year (Danish men) without partner becoming pregnant. BMI, body mass index; NA, not
available.
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supplementary materials for details). To ascertain that
the concentration could be replicated in thawed
samples, samples known to be counted in 0.1 mm deep
chamber were counted again. As anticipated, the results
were replicated and shown to be accurate. From each
semen sample, a smear for morphology evaluation was
made, Papanicolaou stained and ﬁnally assessed accord-
ing to ‘strict criteria’ at the Department of Growth
and Reproduction (GR) at the National Hospital
(Rigshospitalet, RH) in Denmark.
The Faroese semen analyses were performed by three
technicians, who participated in a quality control testing
course at RH and spent 2 weeks there to ensure compar-
able results. Furthermore, every 3 months, ﬁve blinded
samples were sent from RH, and sperm concentration
results were compared with the results from their techni-
cians. Throughout the study period, the variation was less
than 10% compared with the Danish technicians.
Therefore, the methodological differences between the
Faroese and the Danes should be considered very limited.
Reproductive hormones
On the day of the examination, a venous blood sample
was drawn from each participant and centrifuged
(3000 g, 10 min). Serum was subsequently separated and
kept frozen until it was analysed for reproductive hor-
mones at GR at RH. Levels of follicle stimulating
hormone (FSH), luteinising hormone (LH) and sex
hormone-binding globulin (SHBG) were determined
using a time-resolved ﬂuoroimmunoassay (Delﬁa,
Wallac, Turku, Finland). Testosterone (T) was deter-
mined using a COAT-A-COUNT solid-phase radio-
immunoassay (RIA) (Siemens Medical Solutions,
Malvern, Pennsylvania, USA) and oestradiol by RIA
(Pantex, Santa Monica, California, USA).19 Inhibin B
was analysed by a double antibody enzyme-
immunometric assay using a monoclonal antibody raised
against the inhibin βB-subunit in combination with a
labelled antibody raised against the α-subunit. Samples
were analysed for inhibin B in 2009 using kit material
from Oxford Bio-Innovation or in 2010 with kit material
from DSL Beckman, USA. For all hormone assessments,
internal standard samples were analysed and showed no
need to correct for potential interassay variation, includ-
ing the need for correction between the kit materials for
inhibin B from the two suppliers. The free testosterone
index (FT) was calculated from total testosterone and
SHBG using a ﬁxed albumin value according to
Vermeulen et al.20
Physical examination
Participants in the F1 subgroup underwent a physical
examination performed by one of two examiners at the
day of the semen sample delivery. Body weight and height
were measured. The Tanner stage of pubic hair and
genital development were recorded. Any abnormalities in
the testis and penis, the possible presence of varicocele,
hydrocele, hypospadias and testis tumour, the location of
testis in scrotum and their consistency and that of epididy-
mis were recorded. Testicular volumes were determined by
use of a Prader orchidometer, and reported as the mean
of two testes (table 1). Participants in the F2 study did not
undergo a physical andrological examination.
Comparison population: men from the general Danish
population
In Denmark, all young men, except those suffering from
severe chronic diseases (<15%), are required to attend a
compulsory medical examination before they are consid-
ered for military service.5 Men are called upon at the
age of 18–19 years, but some postpone this examination
until completion of their education. Men attending the
compulsory examination are invited to participate in a
semen quality study, using the same basic study design
including a physical examination as the Faroese, irre-
spective of whether they are declared ﬁt for military
service or not. For comparison with results from the
Faroese studies, we utilised results for Danish men exam-
ined in 2006–2010, which has recently been published.12
The detailed description of the study population based
on questionnaire information and results from the phys-
ical examination (see below) is summarised in table 1.
Comparison population: WHO reference group
of fertile men
The Faroese sperm count distribution was compared
with the distribution for fertile men reported as the
WHO reference group.13
Statistics
The crude means, medians, SDs, 5–95 percentiles and
frequencies were used for basic descriptions of obtained
results. The main outcome variables were semen
volume, sperm concentration, total sperm count, per-
centage of motile spermatozoa, percentage of morpho-
logically normal spermatozoa and serum level of the
reproductive hormones. Differences in semen quality
variables and reproductive hormone levels between
groups were tested by linear regression adjusted for sig-
niﬁcant confounders. Semen volume, sperm concentra-
tion and total sperm count were best normalised by a
cubic root transformation before regression analysis to
correct for skewed distribution of residuals. The percen-
tages of motile spermatozoa (ie, WHO class AB+C)
were logit-transformed. Percentages of morphologically
normal spermatozoa were close to normally distributed
and entered the model untransformed. Reproductive
hormone levels were natural logarithmic transformed.
Correlations between reproductive hormone levels were
assessed with Spearman correlation. Between-group dif-
ferences for categorical variables were tested with non-
parametric tests (Mann-Whitney). Total sperm count dis-
tribution differences between the Faroese men and the
WHO reference distribution were tested by χ2 analyses.
Association between year of birth and semen parameters
was tested by linear regression.
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For F2, the abstinence time in hours showed a signiﬁ-
cant positive association to sperm concentration, semen
volume and total sperm count. The effect was most
pronounced for the period below 96 h and less above
(for sperm concentration: β-value=0.011, p=0.01 and
β-value=0.006, p=0.18, respectively). The abstinence time
was not signiﬁcantly associated with sperm concentration
in F1 (β-value=0.0001, p=0.98, and β-value=0.0003, p=0.5,
respectively) or total sperm count. Thus, abstinence
time was entered as piecewise linear functions (linear
splines); that is, one straight line for abstinence below
96 and another straight line for abstinence above 96 for
semen volume, sperm concentration and total sperm
counts. The duration from ejaculation to assessment was
included as a confounder for sperm motility. No con-
founders were detected to affect morphology.
The following factors were evaluated as possible con-
founders for semen parameters and found to have no
inﬂuence (p>0.05): age, body mass index (BMI) (as con-
tinuous variable or categorised as <18.49; 18.5–25; >25),
smoking (yes/no) and season of year (spring (March–
May), summer ( June–August), autumn (September–
November) and winter (December–February)).
The same factors were evaluated as possible confounders
for the reproductive hormones. Signiﬁcant associations
were observed for BMI and age but not for smoking. The
effect of season was not systematic and thus not included as
a confounder. Hour of day of blood sampling was included
as a confounder for reproductive hormones, although it
was only signiﬁcantly associated with oestradiol, T and FT. p
Values below 5% were considered to be statistically signiﬁ-
cant. Analyses were performed using PASW GradPack 19.0
(SPSS Inc, Chicago, Illinois, USA).
RESULTS
In table 1, physical appearance, lifestyle factors, repro-
ductive health and self-reported information on fertility
are displayed for the two subgroups of Faroese men, the
combined Faroese group and the Danish comparison
group. All men had their semen variables assessed.
However, morphology scoring was missing for 50 Faroese
men and 20 Danes, which is reported in table 2. Also,
assessment of testis size was only performed on subgroup
F1, which is stated in table 1. Semen volume was not
recorded for one Faroese man and motility measure was
missing for one man.
The three groups differed in age with the F1 group
being the oldest and the Danish group the youngest.
Similarly, the F1 group had the highest BMI and the
Danish group the lowest. Alcohol intake was lower
among the Faroese men, and more Faroese men had
caused a pregnancy/fathered a child.
Semen variables
Table 2 summarises the semen variables. Sperm concentra-
tions for the Faroese men were lower than for the Danish
men. However, semen volume was higher, and thus the
Table 2 Semen parameters in Faroese and Danish men
Faroese
men (F1)
Faroese
men (F2)
p Value
Faroese men
(F1+F2)
Danish
men (D)
p Value
2007–2009
(N=241)
2009–2010
(N=240)
2007–2010
(N=481)
2006–2010
(N=1274)
Sperm concentration (mill/ml)
Mean (SD) 54 (56) 60 (60) 57 (58) 62 (55)
Median (5–95 percentiles) 38 (1.6–156) 41 (2.2–182) 0.5* 40 (1.9–174) 48 (4.0–169) <0.0005*
Semen volume (ml)
Mean (SD) 4.2 (1.7) 4.0 (1.7) 4.1 (1.7) 3.6 (3.1)
Median (5–95 percentiles) 4.0 (1.9–7.1) 3.9 (1.5–7.2) 0.02* 3.9 (1.8–7.1) 3.3 (1.3–6.3) <0.0005*
Total sperm count (mill)
Mean (SD) 214 (205) 215 (206) 215 (205) 206 (258)
Median (5–95 percentiles) 154 (3–586) 159 (9–638) 0.8* 159 (6–591) 151 (13–559) 0.2*
Normal morphology (%)†‡
Mean (SD) 7.5 (4.3) 6.3 (4.5) 6.9 (4.4) 7.5 (4.9)
Median (5–95 percentiles) 7.5 (1.0–15.0) 5.0 (0.5–15.0) <0.0005‡ 6.5 (0.9–15.0) 7.0 (0.5–16.0) 0.2§
Motile sperm (%)¶
Mean (SD) 70 (22) 58 (13) 64 (19) 65 (16)
Median (5–95 percentiles) 74 (19–95) 59 (35–74) <0.0005** 64 (24–90) 68 (33–85) 0.02**
Period of abstinence (h)
Mean (SD) 80 (38) 86 (35) 83 (37) 77 (96)
Median (5–95 percentiles) 83 (14–167) 83 (35–168) 0.1§ 83 (25–168) 63 (37–134) <0.0005§
*Regression analysis adjusting for duration of abstinence.
†Morphology was missing for 50 Faroese men (F1+F2) and 20 Danish men.
‡Regression analysis without any adjustment.
§Mann-Whitney test.
¶Motile sperm is the sum of progressively motile (WHO class AB) and local motile (WHO class C).
**Regression analysis adjusting for delay from time of ejaculation to assessment of motility.
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total sperm counts did not differ. Similarly, overall motility
and morphology did not differ between the Faroese and
Danes, but it did differ between the two Faroese subgroups
with higher values for the F1-subgroup. Figure 1A shows
the distributions of total sperm counts of all the investi-
gated Faroese men (blue bars) in categories deﬁned from
the reference levels according to centiles as described by
the WHO (green bars). According to the ﬁgure, more
Faroese men had lower sperm counts than the reference
group (p<0.0001).
From the entire group of 481 men, 313 (65%) were
without any prior knowledge of andrological diseases or
conditions that might be associated with risk of impaired
testicular function (cryptorchidism, testicular torsion,
orchitis, epididymitis, varicocele, hydrocele, prostatitis,
hypospadias, phimosis, inguinal hernia, cystitis, sexually
transmitted diseases, diabetes, thyroid diseases, experi-
enced fertility problems). In this subgroup, 244 men
(50% of the entire group) had an ejaculation abstinence
period of more than 48 h. These 244 men also had
lower total sperm counts than men from the WHO refer-
ence group (ﬁgure 1B, lower panel, p=0.0013).
The percentages of morphologically normal spermato-
zoa were inversely associated with year of birth, both for
the entire group of Faroese men (ﬁgure 2A, trend
p=0.002) and for the subgroup of 244 men (ﬁgure 2B,
trend p=0.018). Morphology assessments were done in
four different time periods, but the results did not differ
according to these periods. Similar trends were seen
when the estimates according to year of birth were
adjusted for age, however, with broader CIs of the esti-
mates. No other semen variables were associated with
birth year and age at the time of investigation.
Approximately 14% of the participants were reported to
have fathered a child. The confounder-adjusted estimates
indicated higher sperm concentration, total sperm count,
motility and morphologically normal spermatozoa in these
men in comparison to non-fathers, all non-signiﬁcant
except for motility (p<0.0005). Semen volume was non-
signiﬁcantly lower in the father group (p=0.7). When the
Figure 1 Distribution of total sperm count in Faroese men
(blue bars) in categories defined from the reference levels
according to centiles as described by WHO (green bars). In
(A) all Faroese men are included. In (B) only men having an
ejaculation abstinence period above 48 h and being ‘without
diseases’ (see text for further explanation) are included.
Figure 2 Percentage of morphologically normal
spermatozoa according to year of birth. Whiskers show the
95% confidence interval of the estimated mean. In (A) all
Faroese men are included. In (B) only men having an
ejaculation abstinence period above 48 h and being ‘without
diseases’ (see text for further explanation) are included.
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distribution of total sperm counts for these fathers were
compared with the WHO reference group, no difference
between the groups could be seen (p=0.1).
Physical examination
Only the men in the F1-group had a physical examin-
ation performed. Among these, 95% had a normal
mean testicular volume (ie above 15 ml), which appar-
ently was slightly lower than for the Danish men
(table 1). A total of 2% did not have both testicles in
scrotum, 8% had soft testicles and 4% did not have
adult pubic hair distribution (ie, Tanner stage 5 or 6). A
varicocele was detected in 15% (5.8% grade 1, 7.5%
grade 2 and 1.7% grade 3) of the F1 cohort. In regres-
sion analyses, all semen variable estimates were higher
in men without any varicocele, but they were all non-
signiﬁcant (all p>0.2). Hydrocele was detected in 5%,
and tended to be associated with a lower percentage of
morphologically normal spermatozoa (p=0.05), but not
with other semen variables (all p>0.6).
Smoking and BMI
The men’s tobacco smoking was non-signiﬁcantly asso-
ciated with lower semen volume, sperm concentration
and total sperm counts (all p>0.1) and higher percent-
age of normal forms and motile spermatozoa (p=0.8
and 0.2, respectively). Maternal smoking during preg-
nancy was signiﬁcantly associated with lower total sperm
count (29% reduction, 95% CI 8%; 45%, p=0.02), and
non-signiﬁcantly with semen volume (9% reduction,
95% CI −16%; 2%, p=0.05) and sperm concentration
(22% reduction, 95% CI −40%; 6%, p=0.06). There
were no signiﬁcant associations between maternal
smoking, sperm motility and sperm morphology (p=0.5
and 0.8, respectively). BMI above 25 was not associated
with adverse effects on any semen variable.
Reproductive hormones
Table 3 summarises the reproductive hormone levels for
the two subgroups of Faroese men, the combined group
and the Danish comparison group. Inhibin B tended to
be slightly lower in the Faroese F1 group than in the F2
group, thus showing the same tendency as sperm con-
centration and total sperm count. FSH showed opposite
directions resulting in lower inhibin B/FSH ratio in the
F1 group. In the combined Faroese group, both inhibin
B and FSH individually were higher than in the Danish
group, whereas the inhibin B/FSH ratio was lower. In
2010, the laboratory began to use a different kit material
for the serum inhibin B analyses. However, that the
inhibin B/FSH results did not differ according to this as
is described in the Materials and methods section.
Although statistically signiﬁcant, total testosterone (T)
differed only slightly between the two Faroese groups
and between the combined group and the Danes,.
SHBG, by contrast, was considerably higher for the
Faroese men and with no difference between the F1 and
F2 men. Frequency analyses of the SHBG values divided
into groups (0–10, 10–20, etc.) showed that the higher
SHBG values for the Faroese men were not caused by
higher concentration in a speciﬁc subgroup but an
overall shift to higher levels. Approximately 80% of the
Faroese men had an SHBG concentration below
50 nmol/l while 80% of the Danish men had a concen-
tration below 40 nmol/l. The FT differed between the
two Faroese groups, which combined, however, had non-
signiﬁcantly lower FT than the Danes. Oestradiol was
higher in the F2 group than in the F1 group, thus
leading to higher levels in the combined group of
Faroese men than in the Danish men. The ratios T/LH,
FT/LH and FT/oestradiol were all lower in the Faroese
men than in the Danish men, whereas the estimated
lower total T/oestradiol was non-signiﬁcant.
SHBG and LH were positively correlated with T
(p<0.0005), whereas SHBG and LH did not correlate
(p=0.1). FT was positively correlated with LH and T
(p<0.0005), and negatively but not signiﬁcantly corre-
lated with SHBG (p=0.06)
BMI was negatively associated with T, FT, SHBG,
T/LH, T/oestradiol, FT/oestradiol and inhibin B
(p<0.0005–0.042), and also negatively but non-
signiﬁcantly associated with LH (p=0.3). Faroese
smokers tended to have higher T than non-smokers
(p=0.7, adjusted for BMI effect), whereas the effect on
the Danish men were highly signiﬁcant (p<0.0005). In
the Faroese groups, LH, SHBG, oestradiol, FT/LH,
FT/oestradiol and T/oestradiol tended to be higher in
smokers, although all non-signiﬁcantly. For the Danes,
similar trends were detected, the effect on SHBG and
LH being non-signiﬁcant, whereas the remaining were
signiﬁcant with p values <0.0005–0.05. Further, maternal
smoking during pregnancy for the Faroese men tended
to be associated with lower LH and FT (p=0.04 and
0.02), whereas the effect on the remaining hormone
levels were all highly non-signiﬁcant (p=0.1–0.9).
However, the difference (ie, signiﬁcant levels in table 3)
between the Faroese and Danish hormone levels did not
change when including BMI or age as cofactors in the
regression analyses, indicating that these factors cannot
explain the difference in reproductive hormones
between the Faroese and Danes.
DISCUSSION
This is the ﬁrst study on testicular function to be con-
ducted in the Faroe Islands. These young Faroese men
had a lower sperm concentration but similar total sperm
count compared to Danish men. Recent data have
shown sperm counts to be low in young men from
several European countries, however, slightly higher
than among the Danes.5 21 22 Thus, the semen quality of
Danish men seems to be particularly low, and now we
have shown the Faroese men to have a similar low level.
The low inhibin B/FSH ratio for the Faroese men cor-
roborates the ﬁnding of low sperm counts, and provides
independent evidence of poorer testicular function in
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Table 3 Reproductive hormones levels in Faroese and Danish men
Faroese men (F1) Faroese men (F2)
p Value*
Faroese men (F1+F2) Danish men (D)
p Value*2007–2009 (N=241) 2009–2010 (N=240) 2007–2010 (N=481) 2006–2010 (N=1274)
FSH (IU/l)
Mean (SD) 4.1 (4.7) 3.4 (1.9) 3.8 (3.6) 2.8 (1.8)
Median (5–95 percentile) 3.1 (1.3–8.5) 2.9 (1.1–7.0) 0.05 3.1 (1.2–7.7) 2.5 (1.0–6.0) <0.0005
Inhibin B (pg/ml)
Mean (SD) 196 (79) 220 (84) 208 (82) 189 (70)
Median (5–95 percentile) 192 (76–333) 210 (99–382) 0.04 202 (85–346) 180 (90–318) 0.05
Inhibin B/FSH
Mean 80 (72) 101 (107) 91 (92) 100 (89)
Median (5–95 percentile) 57 (11–203) 70 (17–289) 0.02 64 (13–259) 76 (17–272) <0.0005
LH (IU/l)
Mean (SD) 4.8 (2.4) 4.8 (1.8) 4.8 (2.1) 3.5 (1.5)
Median (5–95 percentile) 4.5 (2.1–8.5) 4.6 (2.1–7.9) 1.0 4.5 (2.1–7.9) 3.3 (1.6–6.3) <0.0005
Testosterone (nmol/l)
Mean (SD) 21 (7) 23(7) 22 (7) 20 (6)
Median (5–95 percentile) 20 (11–32) 22 (14–36) 0.006 21 (12–33) 19 (12–31) <0.0005
Testosterone/LH
Mean 5.0 (2.3) 5.9 (7.2) 5.5 (5.3) 6.5 (2.8)
Median (5–95 percentile) 4.6 (1.9–9.1) 4.6 (2.7–11.6) 0.09 4.6 (2.2–9.4) 6.0 (3.0–12.0) <0.0005
Free testosterone (pmol/l)
Mean 409 (134) 462 (140) 439 (134) 454 (142)
Median (5–95 percentile) 397 (211–633) 442 (262–707) <0.0005 424 (236–686) 432 (269–701) 0.1
Free testosterone/LH
Mean 99 (44) 125 (175) 112 (128) 149 (71)
Median (5–95 percentile) 92 (39–186) 96 (49–212) 0.03 94 (47–201) 134 (65–273) <0.0005
Oestradiol (nmol/l)
Mean (SD) 79 (22) 96 (23) 88 (24) 80 (24)
Median (5–95 percentile) 78 (46–113) 94 (62–140) <0.0005 86 (54–131) 78 (48–125) <0.0005
Testosterone/oestradiol
Mean 268 (83) 243 (69) 255 (78) 258 (70)
Median (5–95 percentile) 262 (140–409) 236 (146–375) <0.0005 243 (145–394) 249 (175–383) 0.1
Free testosterone/oestradiol
Mean 5332 (1567) 4955 (1187) 5143 (1400) 5869 (1768)
Median (5–95 percentile) 5218 (3230–7768) 4876 (3165–7201) 0.002 5026 (3182–7538) 5636 (3519–8956) <0.0005
SHBG (nmol/l)
Mean (SD) 38 (15) 37 (15) 38 (15) 30 (12)
Median (5–95 percentile) 36 (17–62) 35 (19–68) 0.7 36 (18–65) 29 (14–51) <0.0005
Time of blood sampling
Mean (SD) 11 : 56 (2 : 11) 9 : 57 (1 : 29) 10 : 27 (1 : 56) 10 : 04 (0 : 42)
Median (5–95 percentile) 10 : 15 (8 : 40–15 : 40) 9 : 37 (8 : 02–12.45) <0.0005† 10 : 10 (8 : 30–15 : 00) 10 : 00 (9 : 05–11 : 20) 0.6†
*Regression analysis adjusting for hour of day of blood sampling.
†Mann-Whitney test.
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin.
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the Faroese men than in the Danes, although the
medians were at a level where the association between
sperm counts and inhibin B is weakened.23 When evalu-
ating the results against the WHO reference population,
Faroese men also had low sperm counts. The lower T/
LH and FT/LH ratios point towards a lower Leydig cell
capacity among Faroese men compared to Danes. Thus,
the total testicular function among Faroese men may be
at the same or lower level than Danes.
A greater proportion of men from the Faroese study
populations had previously caused a pregnancy, which
also would be expected since these men on average were
almost 6 years older than the Danes. Furthermore,
Faroese people are in general younger when parenting
for the ﬁrst time (25.5 years in 2011),24 and the fertility
rate in the Faroe Islands is the highest in European
countries25 with 2.3 children per woman in 2011.24
Traditionally, the family culture in the Faroe Islands is to
have large families with many children; however, during
the last 40 years, the fertility rate in the Faroe Islands
has decreased from 3.4 children per woman in 1970 to
2.8 children per woman in 1990 to the current fertility
rate of 2.3 children per woman in 2011.24 Thus, the
high birth rate most likely reﬂects socioeconomic factors
rather than male fecundity. Despite this, more Faroese
men from the study populations had experienced fertil-
ity problems than the Danish men. This is in agreement
with the lower sperm concentration found in the
Faroese men, but it should be taken into account that
the Faroese men were asked about fertility problems on
the basis of 6 months unprotected intercourse without
achieving a pregnancy, and for the Danes it was based
on 1 year. Therefore, the Danish men were more likely
to have obtained a successful fertilisation having tried
for twice as long. Furthermore, fewer Danish men may
be aware of a fecundity problem because they were
younger and had not yet tried to conceive.
The Faroese and Danish men were not exactly the
same age. Semen quality has been reported to decline
with increasing age.26–29 However, the Faroese studies
and the comparative Danish studies were conducted at
the same time periods, and the difference in age
between groups is not likely to have inﬂuenced the
semen parameters or the actual age of the participants
which can still be regarded as young. Semen quality
does on average not change between 19 and 23 years of
age, and immaturity seems unlikely to explain the poor
semen quality both among the Faroese and Danish
men.30 Thus, age difference is not likely to explain the
difference in semen quality.
The Faroese men were investigated during a relatively
short time period and also represented narrow birth
cohorts. Despite this, we actually detected an inverse
association between the percentage of morphologically
normal spermatozoa and the year of birth, a trend that
was robust even when controlled for potential confoun-
ders. In a cohort like ours, the effect of birth year may
be difﬁcult to separate from the effect of age. However,
when we modelled age as an explanatory factor and con-
trolled for birth year, the trend effect of age was not
apparent. Thus, our results suggest that younger men
produced ejaculates with lower percentages of normal
spermatozoa. This could be caused by certain unhealthy
lifestyle factors among the younger cohorts, but not the
older cohorts. Our currently existing data do not
support that explanation, however, but the information
we have could also be insufﬁcient to exclude this sugges-
tion. Alternatively, the birth cohort effect could reﬂect
an increasing exposure during fetal life leading to
impaired testicular development, which in adulthood
would be reﬂected by reduced semen quality in line with
the suggested Testicular Dysgenesis Syndrome hypoth-
esis.31 32 The Faroese studies were investigated according
to similar protocols and assessment of sperm concentra-
tion was controlled by the same quality control as the
Danish study. The Faroese technicians were trained at
RH in Denmark and the analyses used in both laborator-
ies were identical, thus reducing the interobserver vari-
ation. Additionally, assessment of sperm morphologies
was performed randomly by a single person. Frequency
of motile sperm, however, is difﬁcult to compare reliably
between different groups. The motility assessment is
highly subjective and controlling for quality control
within this parameter is problematic. Previously, the inter-
laboratory variance of motility has shown to be of signiﬁ-
cant importance.33 Therefore, we hesitate to draw major
conclusions regarding sperm motility.
The recording of abstinence time was obtained differ-
ently in the two Faroese subgroups. In the F1 group, the
men were asked directly by the physician about the
abstinence time while the F2 men themselves wrote
down their abstinence time after they had some time to
consider. This latter procedure is believed to be much
more accurate, as the men were given time to reﬂect
and were not expected to give an immediate verbal
response. This assumption is supported by the fact that
the anticipated relationship between abstinence time
and sperm concentration only was clearly seen in the F2
group. Assuming that the reported abstinence time actu-
ally was longer among the Faroese men, these men still
produced similar numbers of sperm as the Danish men,
suggesting that the sperm production rate is lower in the
Faroese population compared to Danes. This was,
however, only conﬁrmed for sperm concentration but
not total sperm count when the abstinence period was
accounted for in the statistical model.
As explained in the Materials and methods section,
some of the semen samples were analysed with incorrect
counting chambers. However, we corrected for this
potential testing error. In addition, the statistical analyses
performed with or without the 59 samples did not
change the overall results, supporting the assumption
that the corrections made were valid. A major advantage
of the study was that the participants were not selected
on fertility status. According to most of the Danish men,
the main incentive for participation was the ﬁnancial
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compensation.5 The F2 men were part of an existing
birth cohort study, whereas F1 men were randomly
recruited. Thus, we cannot exclude that men with suspi-
cion of infertility may have been more interested in par-
ticipating in the study. However, to control for this, we
deﬁned a subgroup of men with an abstinence period of
more than 48 h and without any prior knowledge of
andrological diseases and without known fertility, and
still found that the same low sperm counts were
detected. This problem with counting chambers, and
the differences in semen quality and population charac-
teristics between the two Faroese subpopulation exempli-
ﬁes one of the main problems when comparing semen
characteristics globally and over time, namely that stan-
dardised methods have to be applied and sufﬁciently
large study populations investigated.
The ﬁnding of low semen quality and lower Leydig cell
function in Faroese men cannot be explained by effects of
confounders. Both high BMI and maternal smoking have
previously been associated with reduced testicular func-
tion in some studies, but not all.34–40 In our cohort, the
effects of these two usually quite robust confounders/
explanatory factors were not obvious on the semen para-
meters, neither on the reproductive hormones. However,
our cohorts may have been too small to detect the effects
of these two factors. Alternatively, other unidentiﬁed
factors may have had a major inﬂuence masking the effect
of BMI and maternal smoking on the semen parameters.
The reason for the low testicular function of the Faroese
young men is unknown, but this population is highly
exposed to POPs derived solely from traditional marine
food, which includes blubber from the pilot whale. Studies
have shown associations between high polychlorinated
biphenyl (PCB) levels and low semen quality, and since
PCBs and p,p’-DDE have the potential to interfere with
sex hormone functions, it is plausible to assume that these
compounds can affect the function of these organs.41
There are some reports on the effect of POPs on male
reproduction in humans, mainly indicating weak negative
effects on sperm motility.41–43 For the two Faroese sub-
groups, we found that the percentage of motile cells was
signiﬁcantly lower compared with Danish men, indicating
that increased exposure to endocrine disruptors can be
one explanation.
Serum SHBG levels for the Faroese men were strik-
ingly higher than in the Danes. SHBG is a sensitive
marker for thyroid function. However, none of the study
subjects were under treatment for hyperthyroidism. We
did not measure thyroid hormones, but the men did not
have any obvious clinical symptoms of hyperthyroidism.
If a high thyroid level in general should explain the
SHBG level, a signiﬁcantly elevated LH and testosterone
in men with low BMI would have been expected, which
was not the case. Therefore, there is no indication that
the high SHBG values are due to hyperthyroidism.
Furthermore, alcohol consumption could not explain
the high levels. One plausible explanation to the high
SHBG levels could be the high PCB exposure
mentioned above. A recent publication from the Faroe
Islands found that SHBG increased at higher PCB expos-
ure, both prenatally and currently. PCBs are known to
affect a variety of liver functions, and it could be specu-
lated that PCB-induced hepatic SHBG synthesis could
play a possible role, although this possibility remains to
be substantiated.44 We cannot elucidate further if PCB
in our current study group can explain the SHBG levels.
It is known that the Faroese population differs genetic-
ally from other populations in many respects. There are
several genetic diseases reported with very high fre-
quency on the Faroese Islands.11 45 However different
genetic composition in populations may contribute to
the explanation of differences in semen quality and
would be worth further exploration.
In conclusion, we found that the semen quality among
Faroese men is at the same low level as reported among
Danish men. This low quality was corroborated by the
reproductive hormone levels in Faroese men. The inﬂu-
ence of environmental exposures and genetic factors on
the semen quality has to be studied further.
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